Insight

Nelson Dusetti

May 5, 2025, 14:24

Nelson Dusetti: Advancing Pancreatic Cancer Research with ARARD Foundation

Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), shared a post on LinkedIn:

“Tumor plasticity and resistance remain major barriers in pancreatic cancer treatment. Thanks to the support of the ARARD Foundation – Home Care Provider, our team is advancing research to better understand and overcome these challenges. This grant supports and strengthens the work of two early-career researchers: Brice Chanez, clinical oncologist at Paoli-Calmettes Institute, and Nicolas Fraunhoffer Ph.D., translational researcher at CRCM – Cancer Research Centre of Marseille. This project relies on the Pancreas-View transcriptomic signature to molecularly stratify pancreatic tumors and uncover key mechanisms of treatment adaptation, plasticity and resistance – paving the way for more personalized therapies.”

More posts featuring Nelson Dusetti.

ARARD Brice Chanez cancer Cancer Research Centre of Marseille CRCM Nelson Dusetti. Nicolas Fraunhoffer OncoDaily Oncology Pancreatic Cancer Paoli-Calmettes Institute

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action